News & Updates

A novel two-injection ovarian stimulation strategy yielded a comparable number of mature (MII) oocytes to a conventional protocol but did not demonstrate noninferiority, according to a recent study presented at ESHRE 2026.

Vaccination against COVID-19 lowers the risk of developing long COVID symptoms, and this protective effect persists for up to 7 months following vaccination, as shown in a retrospective study.

A recent study suggests the clinical value of coronary artery calcium (CAC) when statin treatment decisions are uncertain, especially among individuals with borderline predicted risk.

Very preterm infants are at increased risk of vitamin D deficiency (VDD), defined as 25(OH)D <20 ng/mL, a Thai study has found.

Males hospitalized for new-onset psychosis with confirmed cannabis exposure (CAP) demonstrate better cognitive function, lower cortical excitatory/inhibitory (E/I) balance, fewer negative symptoms, and greater improvement in mood symptoms than those with noncannabis-associated psychosis (NCAP), a study has shown. However, resuming cannabis use may result in relapse.

In patients with stroke, administering standard-dose tenecteplase before mechanical thrombectomy is associated with a higher rate of early substantial reperfusion compared with low-dose alteplase, without compromising functional and safety outcomes, according to a study.

Once-daily oral treatment with the JAK inhibitor upadacitinib delivers clinically meaningful facial and total body repigmentation in adults and adolescents with non-segmental vitiligo, according to the phase III Viti-Up 1 and 2 trials.

Several copy number variants (CNVs) contribute to severe phenotypes in schizophrenia spectrum disorders (SSDs), and disruptions in foetal brain development are associated with poor cognition, suggests a study.